Table 2 Association of pTCD8+CD28− with the clinical characteristics.
Clinical characteristics | Correlation coefficient | P value |
|---|---|---|
Age of diagnosis | 0.030 | 0.633 |
≤45 years (n = 83) | ||
>45 years (n = 169) | ||
Age of sample collection | 0.022 | 0.723 |
Primary T stage | 0.024 | 0.697 |
I (n = 59) | ||
II (n = 122) | ||
III (n = 22) | ||
IV (n = 28) | ||
Primary N stage | 0.026 | 0.668 |
0 (n = 64) | ||
1 (n = 59) | ||
2 (n = 47) | ||
3 (n = 67) | ||
Primary tumoral grade | −0.026 | 0.703 |
I (n = 5) | ||
II (n = 144) | ||
III (n = 68) | ||
Liver | −0.123 | 0.052 |
No (n = 159) | ||
Yes (n = 93) | ||
Lung | −0.011 | 0.864 |
No (n = 155) | ||
Yes (n = 97) | ||
Brain | −0.104 | 0.100 |
No (n = 240) | ||
Yes (n = 12) | ||
Bone | −0.189 | 0.003 |
No (n = 159) | ||
Yes (n = 93) | ||
Lymph | −0.152 | 0.016 |
No (n = 92) | ||
Yes (n = 160) | ||
Chest | 0.063 | 0.320 |
No (n = 211) | ||
Yes (n = 41) | ||
Uncommon metastatic lesion | −0.085 | 0.177 |
No (n = 219) | ||
Yes (n = 33) | ||
Visceral metastasis | −0.081 | 0.198 |
No (n = 89) | ||
Yes (n = 163) | ||
Number of metastatic sites | −0.200 | 0.001 |
1 (n = 90) | ||
2–3 (n = 132) | ||
≥4 (n = 30) | ||
DFS | −0.103 | 0.156 |
≤36 months (n = 104) | ||
>36 months (n = 81) | ||
Application of anti-HER2 therapy | 0.009 | 0.892 |
No (n = 29) | ||
Yes (n = 223) | 0.030 |
